Stress-induced bowel disorder-relieving agent comprising specific lactobacillus gasseri strain or treatment product thereof

A technology of Lactobacillus gasseri, stress, used in the field of mitigants

Inactive Publication Date: 2015-07-22
ASAHI GRP HLDG LTD
View PDF11 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] Daisuke Sawada et al., The 10th Symposium on Lactic Acid Bacteria (2011), the Netherlands, Federation of European Microbiological Societies (FEMS) and Netherlands Society for Microbiology (NVvM) (Non-Patent Document 2), describe the effect on irritable bowel Syndrome (IBS) patients were given CP2305 live bacteria, but there is no record for the relief of diarrhea symptoms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stress-induced bowel disorder-relieving agent comprising specific lactobacillus gasseri strain or treatment product thereof
  • Stress-induced bowel disorder-relieving agent comprising specific lactobacillus gasseri strain or treatment product thereof
  • Stress-induced bowel disorder-relieving agent comprising specific lactobacillus gasseri strain or treatment product thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0142]

[0143] Inoculate Lactobacillus gasseri CP2305 strain (number of bacteria 10 3 a ~ 10 4 ), cultured at 37°C for 19 hours.

[0144] After culturing for 19 hours, this 15-ml polypropylene test tube with an inner diameter of 15 mm was inserted into a sufficient amount of ice above the liquid level in the test tube, rapidly cooled (on ice), and kept for 5 hours. This cultivation and cooling were repeated 80 times, and a strain with high low temperature tolerance was bred.

[0145] In this specification, "on ice" refers to a state in which 10 ml of culture solution is placed in a 15 ml test tube made of polypropylene with an inner diameter of 15 mm, and the test tube is cooled by inserting a sufficient amount of ice above the liquid level in the test tube. .

[0146] In addition, the composition of the "food additive medium" used in this specification is as follows (Table 1).

[0147] [Table 1]

[0148] Composition of food additive medium

[0149] compositi...

Embodiment 2

[0157]

[0158] It should be noted that, as a method for producing a low-temperature tolerant strain, for example, the CP2305 strain tends to have a reduced survival rate at temperatures below 10°C. Therefore, as a method for producing a low-temperature tolerant strain, the target strain is cultured in a culture solution (for example: a food additive medium) at a moderate culture temperature (for example: about 37°C) and for a moderate culture time (for example: about 19 hours). After culturing, the culture solution is exposed for a moderate time at a temperature below 10°C, preferably below 7°C, more preferably below 5°C, more preferably below 3°C, below 2°C, or below 1°C (for example: 5 hours), and, if necessary, by repeating their cultivation and exposure to low temperature, strains resistant to low temperatures at the target temperature were produced.

Embodiment 3

[0160] SD male rats (4-week-old, manufactured by Charles River Laboratories) were bred under a 12-hour light-dark cycle (lighting on for 12 hours from 8 o'clock) for 1 week, and then allowed to freely ingest the test bacterial cell mixture bait for 3 weeks as follows.

[0161] a) CRF-1 powder bait from Oriental Yeast Co., Ltd. was used as bait.

[0162] b) The number of bacteria contained in 25 g of the above-mentioned bait (CRF-1) is 2.0×10 10 The freeze-dried powder (0.25 g of the freeze-dried powder was compounded with respect to the bait CRF-1: 25 g) of each test cell was used as the test cell compounded bait.

[0163] c) Allow them to freely ingest the mixed bait of the test bacteria for 3 weeks.

[0164] d) The food intake of the bacteria in this test is estimated to be about 2.0×10 10 pcs / day.

[0165] e) Let 19 animals in each group ingest.

[0166] After 3 weeks, a CRF (Corticotropin Releasing Factor, manufactured by Anaspec, USA) solution was intraperitoneally ad...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present application provides: Lactobacillus gasseri strain CP2305 (FERM BP-11331), Lactobacillus gasseri strain CP2305s (NITE BP-1405), or a variant strain (e.g., a psychrotolerant variant strain) of Lactobacillus gasseri strain CP2305 (FERM BP-11331) or strain CP2305s; a method for producing the variant strain; a stress-induced bowel disorder-relieving agent which is characterized by comprising, as an active ingredient, the variant strain, a treatment product of cells of the variant strain or a mixture thereof; and a food additive, an animal additive, an animal feed and a pharmaceutical composition, each of which contains the relieving agent.

Description

technical field [0001] The present invention relates to a reducer (or inhibitor) of excessive water secretion in the intestinal tract of a subject, or a pressure-sensitive Relief agents (or inhibitors) of symptoms of bowel disorders, especially stress diarrhoea. [0002] The present invention also relates to a novel cold-tolerant Lactobacillus gasseri strain and a production method thereof. [0003] The present invention further relates to a reliever (or inhibitor) of stress bowel disorder comprising the above-mentioned cold-tolerant Lactobacillus gasseri strain or a processed product thereof as an active ingredient. [0004] The present invention also relates to food additives or animal feed additives, or food or pharmaceutical compositions containing the above-mentioned alleviating agent (or inhibitor). Background technique [0005] As for prior art documents showing the possibility that lactic acid bacteria of the genus Lactobacillus (Lactobacillus) are effective for st...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/747A23K1/16A23L1/30A61P1/04A61P1/12A61P25/02C12N1/20C12R1/245A23K20/00A23L2/52A23L33/135
CPCC12N1/20A23K10/16A23K10/18A23L33/135A61K35/747A23V2002/00A61K2035/115A61P1/12C12R2001/225C12N1/205A23V2200/32A23V2400/145A23L2/52A61K9/0056
Inventor 泽田大辅藤原茂
Owner ASAHI GRP HLDG LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap